Status:
UNKNOWN
Additional Minocycline Pleurodesis After Thoracoscopic Procedures for Primary Spontaneous Pneumothorax
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Pneumothorax
Eligibility:
All Genders
10-50 years
Phase:
PHASE3
Brief Summary
To test if additional minocycline pleurodesis after thoracoscopic procedures can reduce the rates of ipsilateral recurrence for patients with primary spontaneous pneumothorax.
Detailed Description
Patients and Methods Study design This study is a randomized trial of additional minocycline pleurodesis after VATS for primary spontaneous pneumothorax. It was begun in June 2001 in Thoracic Surgical...
Eligibility Criteria
Inclusion
- All patients requiring VATS caused by recurrent, persistent, or contralateral spontaneous pneumothorax as well as by spontaneous hemopneumothorax were eligible for this study.
Exclusion
- greater than 50 years of age, with underlying pulmonary disease, previous ipsilateral thoracic operation, allergy to tetracycline or minocycline, and unwilling to receive randomization.
Key Trial Info
Start Date :
June 1 2001
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00154895
Start Date
June 1 2001
End Date
March 1 2005
Last Update
October 20 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yung-Chie Lee
Taipei, Taiwan, 100